BNOX News

The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara (IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings. Samsara (IOT) priced at the high end to raise $805 million at a $12.4 billion market cap....read more

Bionomics, an Australian Phase 2 biotech developing allosteric ion channel modulators for CNS disorders, raised $20 million by offering 1.6 million ADSs at $12.35, below the as-converted last close of its shares on the ASX ($15.66). Insiders had indicated on $15 million worth of ADSs in the offering (75% of the deal). Bionomics is developing novel, allosteric ion channel modulators...read more

Bionomics, an Australian Phase 2 biotech developing allosteric ion channel modulators for CNS disorders, announced terms for its IPO on Monday. The Eastwood, Australia-based company plans to raise $25 million by offering 1.6 million ADSs at $15.45, the as-converted last close of its shares on the ASX (BNO). Insiders intend to purchase $15 million worth of ADSs in the offering (60%...read more

The IPO market got a break during the shortened holiday week, with just one IPO and six SPACs. New issuers continued to join the pipeline ahead of the final stretch of 2021, with seven IPOs and 17 SPACs submitting initial filings. Air purification company AeroClean Technologies (AERC) priced its Reg A+ IPO at the low end to raise $25 million at a $139 million...read more